So-Young International Inc. (SY) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $2.74. It has a SharesGrow Score of 49/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of SY = $1.19 (-56.6% from the current price, the stock appears overvalued). Analyst consensus target is SY = $1 (-70.8% upside).
Valuation: SY trades at a trailing Price-to-Earnings (P/E) of -10.1 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.3.
Financials: revenue is $1.5B, +6%/yr average growth. Net income is $236M (loss), growing at -892.7%/yr. Net profit margin is -15.9% (negative). Gross margin is 47.8% (-20.9 pp trend).
Balance sheet: total debt is $300M against $1.6B equity (Debt-to-Equity (D/E) ratio 0.19, conservative). Current ratio is 1.89 (strong liquidity). Debt-to-assets is 11.3%. Total assets: $2.7B.
Analyst outlook: 5 / 5 analysts rate SY as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 63/100 (Pass), Growth 40/100 (Partial), Past 25/100 (Fail), Health 100/100 (Pass), Moat 40/100 (Fail), Future 64/100 (Pass), Income 10/100 (Fail).
